Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines
- PMID: 7871641
- DOI: 10.1007/BF00541904
Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines
Abstract
Treatment of renal cell carcinoma (RCC) by conventional chemotherapy and immunotherapy has resulted in minimal remissions. Alternative forms of therapy are therefore being sought. The present study investigated the sensitivity of RCC cell lines to several toxins used alone and in combination with other agents. RCC lines were relatively sensitive to the direct cytotoxic effect of diphtheria toxin (DTX), Pseudomonas aeruginosa exotoxin A (PEA) and ricin. Furthermore, DTX in combination with tumor necrosis factor-alpha (TNF-alpha) resulted in synergistic cytotoxic activity. The mechanism of synergy was examined. A possible mechanism of resistance to TNF-alpha in tumor cells is the expression of TNF-alpha mRNA or protein. R11 cells did not constitutively express mRNA for TNF-alpha, however, treatment of R11 cells with TNF-alpha induced the expression of TNF-alpha mRNA. When DTX was used in combination with TNF-alpha, the level of TNF-alpha mRNA induced by TNF-alpha was markedly reduced. These studies suggest that DTX in combination with TNF-alpha can overcome the resistance of RCC lines and that the marked downregulation of TNF-alpha mRNA by DTX may play a role in the enhanced cytotoxicity seen with the combination of DTX and TNF-alpha. Furthermore, the combination treatment might also potentiate the antitumor host responses. The implications of these findings in clinical therapy are discussed.
Similar articles
-
Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.J Immunol. 1992 Sep 15;149(6):2089-94. J Immunol. 1992. PMID: 1517572
-
Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization.J Urol. 1994 Jun;151(6):1697-702. doi: 10.1016/s0022-5347(17)35347-8. J Urol. 1994. PMID: 8189599
-
Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.Cancer. 1994 Feb 1;73(3):730-7. doi: 10.1002/1097-0142(19940201)73:3<730::aid-cncr2820730338>3.0.co;2-x. Cancer. 1994. PMID: 8299097
-
Immunotoxins and recombinant toxins for cancer treatment.Important Adv Oncol. 1994:3-19. Important Adv Oncol. 1994. PMID: 8206493 Review. No abstract available.
-
Clinical trials of targeted toxins.Semin Cancer Biol. 1995 Oct;6(5):307-17. doi: 10.1006/scbi.1995.0039. Semin Cancer Biol. 1995. PMID: 8562908 Review.
Cited by
-
Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences.Int J Clin Exp Med. 2010 Sep 21;3(4):270-82. Int J Clin Exp Med. 2010. PMID: 21072261 Free PMC article.
-
Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.J Virol. 1997 Aug;71(8):6218-24. doi: 10.1128/JVI.71.8.6218-6224.1997. J Virol. 1997. PMID: 9223521 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical